PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency
Ana P. Montaldi Sarah Caroline Gomes de Lima; Paulo Roberto D'Auria Vieira Godoy; Danilo Jordão Xavier; Elza Tiemi Sakamoto-Hojo
Oncology Reports Athens v. 44, n. 5, p. 2275-2287, 2020Athens 2020
Localização: FFCLRP - Fac. Fil. Ciên. Let. de R. Preto (pcd 3184204 Acervo Digital )(Acessar)